Skip to main content

Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations

Analysts at Bank of America initiated coverage on Aduro BioTech Inc (NASDAQ: ADRO) with a Buy rating. The target price for Aduro Biotech is set to $40. Aduro Biotech shares closed at $30.85 on Friday.

Analysts at Evercore Partners initiated coverage on Virtu Financial Inc (NASDAQ: VIRT) with a Buy rating. The target price for Virtu Financial is set to $25. Virtu Financial shares closed at $22.30 on Friday.

Analysts at Oppenheimer initiated coverage on Godaddy Inc (NYSE: GDDY) with a Outperform rating. The target price for Godaddy is set to $31. Godaddy shares closed at $24.88 on Friday.

RBC Capital initiated coverage on KemPharm Inc (NASDAQ: KMPH) with a Outperform rating. The target price for KemPharm is set to $18. KemPharm shares closed at $12.05 on Friday.

Analysts at Deutsche Bank initiated coverage on Wix.Com Ltd (NASDAQ: WIX) with a Hold rating. The target price for Wix.com is set to $25. Wix.com shares closed at $23.75 on Friday.

Deutsche Bank initiated coverage on Endurance International Group Hldgs Inc (NASDAQ: EIGI) with a Hold rating. The target price for Endurance International Group is set to $19. Endurance International Group shares closed at $20.96 on Friday.

Analysts at Guggenheim Securities initiated coverage on Paratek Pharmaceuticals Inc (NASDAQ: PRTK) with a Buy rating. The target price for Paratek Pharmaceuticals is set to $37. Paratek Pharmaceuticals' shares closed at $26.56 on Friday.

RBC Capital initiates coverage on Godaddy Inc (NYSE: GDDY) with a Outperform rating. The target price for Godaddy is set to $30. Godaddy shares closed at $24.88 on Friday.

Analysts at Guggenheim Securities initiated coverage on Egalet Corp (NASDAQ: EGLT) with a Buy rating. The target price for Egalet is set to $24. Egalet shares closed at $9.10 on Friday.

Wedbush initiated coverage on Cidara Therapeutics Inc (NASDAQ: CDTX) with a Outperform rating. The target price for Cidara Therapeutics is set to $22. Cidara Therapeutics shares closed at $14.94 on Friday.

Latest Ratings for ADRO

DateFirmActionFromTo
Jan 2020SVB LeerinkMaintainsOutperform
Jan 2020Cowen & Co.DowngradesOutperformMarket Perform
Dec 2019H.C. WainwrightMaintainsBuy

View More Analyst Ratings for ADRO
View the Latest Analyst Ratings

 

Related Articles (VIRT + ADRO)

View Comments and Join the Discussion!

Posted-In: Top InitiationsInitiation Analyst Ratings

Latest Ratings

StockFirmActionPT
ICADGuggenheimInitiates Coverage On24.0
SMBKRaymond JamesUpgrades27.0
WNSNeedhamMaintains88.0
EFXNeedhamMaintains260.0
GOOGLJefferiesMaintains2,700.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com